Key Stories from the past week: A Golden Milestone

Key Stories from the past week: A Golden Milestone

Macro
Saxo Be Invested
Saxo

Less noise from the Oval Office this week but the tariff tit-for-tat continues. Volatility is the outcome sparking investor nerves but also presenting market opportunities. Gold is the haven winner reaching $3,000. Similar to last week, Nasdaq futures saw heavy trading on the Saxo platform as the underlying index remains under pressure (-10% ytd). This week Novo Nordisk topped the list for the most trading clients with a strong skew to the buy side at lows not seen since 2023. US inflation numbers were soft, while positive for rate cuts it is a fear for growth. More below on this week’s key stories. 


Breaking $3,000
Gold reaches record $3,000 per ounce as investors flock into havens on potential growth impact of tariffs. Gold bullion-backed ETF holdings rose to about 2,687 tons which is most since Nov 2023.
Gold surges past USD 3,000 as haven demand grows

Wall Street’s “Fear Guage”
At the time of writing, VIX is at 24 and has a 1-week average of 25.96, this versus the long-term average of around 19.5. Fuelled by trade wars and market uncertainty, volatility can provide short-term fear while long-term investors should remain focused.
Volatility Explained
How to stay on track in a volatile market

EUR strength continues
Last week’s fiscal U-turn initiated the rally in Euro, and news flow continues to reinforce that rhetoric. The fundamentals indicate support could push EURUSD to a multi-year range of 1.12+, but for now the rally takes a breath.
Where does EURUSD find support?

Roche/Zealand pact
Zealand Pharma’s pact with Roche to co-develop and co-commercialise the Danish company’s experimental obesity drug Petrelintide adds another big player to the weight loss drug market. Shares in Novo Nordisk fell - 4.3% on the news to close at a 52-week low.
Roche boosts drug pipeline


Next week will again be led by political and geopolitical developments. We should have clarity over the next US spending bill while tariff spats and talks over a ceasefire in Ukraine continue. The economic calendar brings US Feb Retail Sales on Monday. Bank of Japan rate decision, EU Feb CPI and then US FOMC rate decision on Wednesday. Swiss and Bank of England rate decisions will be announced on Thursday. Scheduled earnings include several prominent Chinese companies XPeng, Tencent Music (Tues), PDD Holdings (Thurs), Nio Inc (Fri). In the US we highlight Nike, Micron, Fedex, which are all due out Thursday.

Quarterly Outlook

01 /

  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992